Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse

$549,652R01FY2020HLNIH

Duke University, Durham NC

Investigators

Karl-Dimiter Bissigcontact

Linked publications & trials

Paper 37075130 Paper 34135476 Paper 32601395 Paper 32578942 Paper 32150344 Paper 32039390 Paper 30170115 Paper 30093418 Paper 30075114 Paper 29631939 Paper 29259231 Paper 29018834 Paper 28659616 Paper 28487442 Paper 28300165 Paper 27572891

View original record on NIH RePORTER →